The Russell 2000 Was the Only Major Index to Fall in the Week to Oct. 9, Down 0.91%, While the Micro-Cap ETF Lost 1.97% and Three IPOs Priced, One of Them a SPAC

Small stocks spent the week to Friday, Oct. 9 going the other way from large ones. TheStreet's market wrap, time-stamped 4:00 p.m. Eastern on Oct. 9, recorded the Russell 2000 at 2,808.57, up 14.45 points or 0.52% on the day (the Oct. 9 index level here is TheStreet's print; FTSE Russell's official close was not available on its public pages, and other feeds may show a level a point or two different), while the S&P 500 closed at 7,811.51 (+0.59%), the Dow at 51,655.01 (+0.83%) and the Nasdaq Composite at 27,366.17 (+0.64%). On the week, the same wrap said, 'The Russell 2000 (-0.91%) was the only major index to decline,' against gains of 1.15% for the Dow, 0.95% for the S&P 500 and 0.19% for the Nasdaq.
The path within the week is visible in Yahoo Finance's historical table for the index: 2,832.90 on Friday, Oct. 2; 2,847.14 on Monday, Oct. 5; 2,830.30 on Tuesday; 2,793.20 on Wednesday, Oct. 7, the week's low close; and 2,794.13 on Thursday. Friday's rebound was not enough to recover Wednesday's drop. (Markets are closed Saturday; there is no Oct. 10 price action to report.)
Further down the capitalisation ladder the week was worse. The iShares Micro-Cap ETF (IWC), which tracks the Russell Microcap Index, closed at 183.00 on Oct. 9 against 186.68 on Oct. 2, according to Nasdaq's historical table for the fund — a 1.97% weekly decline by our arithmetic, roughly double the Russell 2000's. The fund's closes were 187.32 on Oct. 5, 185.39 on Oct. 6, 183.36 on Oct. 7 and 182.79 on Oct. 8, so unlike the Russell 2000 it kept falling into Thursday. The iShares Russell 2000 ETF (IWM) closed at 278.94 from 281.52, down 0.92% by our arithmetic, in line with the index.
A fortnight back the picture is similar. IWC closed at 187.77 on Sept. 25, so the two-week decline runs to about 2.5% (our arithmetic). That makes two consecutive down weeks for the fund on these closes.
The new-issue count for the week came from Renaissance Capital's weekly recap, printed Oct. 9: 'Two biotechs priced IPOs this past week and more joined the pipeline, along with a billion-dollar data center developer, an emerging markets fintech, and a dental treatment company.' Its pricing table lists three deals: TRex Bio (TRXB), which 'priced at the low end to raise $117 million at a $422 million market cap' and 'finished flat'; Pine Tree Acquisition (PAXGU), a $100 million blank-check company that the recap's table shows pricing in line with its midpoint with a 0% first-day return; and Retension Pharmaceuticals (RTSN), which 'upsized and priced at the midpoint to raise $45 million at a $114 million market cap' and 'finished down 12%.' The recap counts '10 Filings During the Week of October 5th, 2026.'
Nasdaq's own IPO calendar for October shows one pricing in the Oct. 5-9 window: Pine Tree Acquisition Corp., 10,000,000 units at $10.00 for $100,000,000 on the Nasdaq Global Market, priced Oct. 6. The calendar's other October pricings were Chilwa Minerals Ltd, 625,000 shares at $5.60 for $3,500,000 on the Nasdaq Capital Market on Oct. 1, and, on the NYSE side of the same calendar, Southport Acquisition Corp. II at $200,000,000 the same day. Chilwa's was the smallest of the three October pricings and the only one on the Capital Market.
We ran our own check against EDGAR. A full-text search of Form 424B4 final prospectuses filed Oct. 5 through Oct. 9 containing the phrase 'initial public offering' returned four filers: Pine Tree Acquisition Corp. (Oct. 6), Basel Medical Group Ltd (Oct. 8), and TRex Bio, Inc. and Retension Pharmaceuticals, Inc. (both Oct. 9). Basel Medical Group already trades as BMGL, so its prospectus is a follow-on rather than a debut; that leaves three true IPO prospectuses, matching Renaissance's count. This is our tally, not a published one.
The micro-cap end of the pipeline is where the week's more telling items sit. Renaissance reported on Oct. 8 that Australian metal-powder producer Amaero 'revived its US IPO plans on Thursday with a new SEC filing disclosing a lower proposed share offering,' and now plans to 'raise $20 million by offering 3.9 million shares at an assumed offer price of $5.15,' down from an earlier $53 million (7.5 million shares at $7.06) — a cut of about 60%, with a fully diluted market value of $143 million, 35% lower than the previous terms. The company, listed on the ASX as 3DA, proposes the Nasdaq ticker AMRO; Renaissance says 'IPO timing has not been determined.'
Two smaller filings and one withdrawal round out the small-deal ledger. Renaissance's headlines record Patriot Mobile filing for a $10 million IPO on Oct. 9 and Malaysia-based electrical distributor LPC filing for a $19 million US IPO on Oct. 2. On Oct. 7, Canadian push-to-talk device maker Siyata PTT withdrew its plan for a direct listing on Nasdaq; Nasdaq's calendar lists the withdrawn deal at 6,112,327 shares with no dollar value.
Blank-check supply kept coming. Beyond Pine Tree's pricing, Renaissance logged SPAC filings or term changes from Tang Capital Acquisition ($75 million, filed Oct. 6), Arca Nova Acquisition ($100 million, Oct. 2), Allarity Acquisition (units cut 20% ahead of an $80 million deal, Oct. 6) and Calm Seas Acquisition (units cut 25% ahead of a $200 million deal, Oct. 8). Nasdaq's filed list for October also shows New Iceland Arctic Acquisition at $115 million after an earlier $143.75 million version appears under withdrawn.
For scale against the broader IPO market, Renaissance's recap states that 'As of 10/8/2026, the Renaissance IPO Index was up 16.3% year-to-date, while the S&P 500 was up 14.4%.' Two of the fortnight's more striking single-session micro-cap moves, both covered separately and both from Nasdaq's historical tables, were Alpha Modus Holdings, which closed at $3.49 on Oct. 2 from $1.17, and BIO-key International, whose $3.12 close on Sept. 29 had unwound to $1.67 by Friday.
One more name moved on Friday itself. Veea Inc. (Nasdaq: VEEA) closed at $5.70 on Oct. 9 from $3.87 on Oct. 8, on 83,591,400 shares, per Nasdaq's historical table, its third session above 60 million shares in seven. The company's 8-Ks that week disclosed $1.65 million of 10% demand notes from NLabs Inc., 'a principal stockholder of the Company and an affiliate of the Company's Chief Executive Officer,' a director's resignation from the board while remaining chief revenue officer, and committee appointments. None of the filings addresses the trading.
What comes next: Renaissance's week-ahead note, also dated Oct. 9, says 'biotechs continue to tap the public market, with two more on the calendar for the week ahead' — Iambic Therapeutics (IAM), $150 million at $15 to $17, and City Therapeutics (CTY), $175 million at $17 to $19 for a market cap it puts at $1.0 billion. Neither is a micro-cap. Whether Amaero, Patriot Mobile or LPC set a date is not yet known, and the Russell Microcap Index's own official weekly close was not available from FTSE Russell's public pages at the time of writing, which is why the ETF stands in for it here.
Sources & further reading
- TheStreet, 'Stock Market Today (Oct. 9, 2026): Dow, S&P 500 end week higher as market rallies into earnings season' — Market Wrap 4:00 p.m. EDT and Look Back 4:13 p.m. EDT
- Yahoo Finance, Russell 2000 (^RUT) historical data table
- Nasdaq, iShares Micro-Cap ETF (IWC) historical data; the IWM table (nasdaq.com/market-activity/etf/iwm/historical) and VEEA table (nasdaq.com/market-activity/stocks/veea/historical) are the same site's equivalents
- Renaissance Capital, 'US IPO Weekly Recap: Biotech IPOs keep flowing as data center developer DayOne joins the pipeline', Oct. 9, 2026
- Renaissance Capital, 'US IPO Week Ahead: Biotech remains a bright spot in a 2 IPO week', Oct. 9, 2026
- Renaissance Capital, 'Metal powder producer Amaero revives Nasdaq listing plans, slashing deal size by about 60% ahead of $20 million IPO', Oct. 8, 2026
- Renaissance Capital, IPO News headline index (Oct. 2-9, 2026 entries on LPC, Arca Nova, Tang Capital, Allarity, Siyata PTT, Calm Seas, Patriot Mobile)
- Nasdaq, IPO Calendar — October 2026 (priced, filed, withdrawn)
- Veea Inc., Form 8-Ks filed Oct. 2 (NLabs demand notes), Oct. 6 (audit committee appointment) and Oct. 9, 2026 (director resignation, compensation committee appointment) — EDGAR filing index
